PeptideStack
5.2kquestions
20kanswers
220users

What does SOUL tell me about vomiting at the 2.5 mg dose?

Asked 4 Apr 2025Modified 16 months agoViewed 2.8k times
7

Stated plainly: SOUL · vomiting · 2.5 mg.

I have read the primary source rather than the summary, which has left me with more questions.

I understand the headline. I do not understand the footnotes, and the footnotes look important.

How should I read this, and where are the traps?

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

913 questionsgi-side-effects
gi-side-effects

The gastrointestinal cluster as a whole - nausea, vomiting, diarrhoea, constipation, reflux, early satiety - with trial incidence rates, dropout…

416 questionstitration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

444 questions
shareeditfollowflag
BB
askedbac_or_bust37k1384 Apr 2025
7Small correction: the units in the third paragraph should be micrograms, not milligrams. – eighty_six_hours 24 days ago
8Do you have a reference for the last claim? Not disputing it, just want to read it. – claudia_ferrante 2 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 2.8k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.